DRMA
Dermata Therapeutics, Inc.Company with tickers: DRMA, DRMAW
CIK
1853816
CUSIP
249845504
Shares Outstanding
4,022,143
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $1,926,382 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Research & Development | $383,724 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $-1,926,382 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-1,847,706 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-0.48 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-0.48 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |